JLK, a medical artificial intelligence (AI) specialist company led by CEO Kim Dongmin, announced on November 11 that it will participate in the 41st ...
Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback